These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1273376)

  • 1. [The treatment of ascites in hepatic cirrhosis].
    Franquelo Ramos E; Huelin Benítez J; Franquelo Villalonga E
    Rev Esp Enferm Apar Dig; 1976 May; 47(5):605-10. PubMed ID: 1273376
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of intravenous mannitol in mobilization of resistant cirrhotic ascites.
    Raza MA; Qureshi UF; Humayoun MA; Waseem T; Akram J
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):184-8. PubMed ID: 21183857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of oral isosorbide and intravenous mannitol as adjuncts to the diuresis of patients with cirrhosis of the liver.
    Gagnon O; Gertman PM; Iber FL
    Am J Med Sci; 1967 Sep; 254(3):284-95. PubMed ID: 6054532
    [No Abstract]   [Full Text] [Related]  

  • 4. Human atrial natriuretic peptide (ANP) for the treatment of patients with liver cirrhosis and ascites.
    Brabant G; Jüppner H; Kirschner M; Böker K; Schmidt FW; Hesch RD
    Klin Wochenschr; 1986; 64 Suppl 6():108-11. PubMed ID: 2948056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of hepatic ascites using Fursemide].
    Bemvenuti GA; Job JM
    Hospital (Rio J); 1968 Nov; 74(5):1601-38. PubMed ID: 5305338
    [No Abstract]   [Full Text] [Related]  

  • 6. Bumetanide in the treatment of hepatic ascites.
    Ring-Larsen H
    Postgrad Med J; 1975; 51 Suppl 6():77-81. PubMed ID: 1105536
    [No Abstract]   [Full Text] [Related]  

  • 7. [The diuretic effect of demethylchlortetracycline in non-compensated hepatic cirrhosis].
    Ronchi E; Cattani F; Croce G; Magri F; Cappellini F; Rosati R; Lucchelli PD
    Recenti Prog Med; 1981 Apr; 70(4):418-32. PubMed ID: 6789413
    [No Abstract]   [Full Text] [Related]  

  • 8. High doses of spironolactone in the treatment of liver cirrhosis with ascites.
    Papadoyanakis N; Darsinos J; Alexandrou K; Karli J
    Br J Clin Pract; 1972 Jan; 26(1):27-32. PubMed ID: 5025912
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of diuretics from the functional viewpoint. 7. Treatment of edema. (2). Treatment of edema and ascites caused by heart failure or liver cirrhosis].
    Furukawa T
    Saishin Igaku; 1965 Jul; 20(7):1743-58. PubMed ID: 5884753
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal insufficiency caused by diuretics in liver cirrhosis with ascites].
    Bosch J; Arroyo V; Rodes J; Teres J; Bordas JM; Bruguera M
    Rev Clin Esp; 1973 Dec; 131(5):375-82. PubMed ID: 4779095
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gentamicin in the therapy of hepatic cirrhosis].
    Residori GF
    G Ital Chemioter; 1969; 16(1):205-16. PubMed ID: 5404099
    [No Abstract]   [Full Text] [Related]  

  • 13. [Letter: action of beta-blocking agents in decompensated cirrhosis].
    Sabbah A
    Nouv Presse Med; 1976 Jan; 5(2):91. PubMed ID: 1264644
    [No Abstract]   [Full Text] [Related]  

  • 14. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
    Traina M; Vizzini GB
    Minerva Med; 1986 Jan; 77(3-4):87-91. PubMed ID: 3511409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience in the treatment of diuretic-resistant ascites in liver cirrhosis by intravenous infusion of autogenous ascitic fluid].
    Matsuoka K; Ueda Y; Kimura M; Mashiba Y; Kitsuki K
    Naika; 1971; 28(1):163-7. PubMed ID: 5565686
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rational use of diuretics in hepatic cirrhosis].
    Vagge R; Cavatorta F; Queirolo C
    G Clin Med; 1983; 64(3-4):116-23. PubMed ID: 6884638
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of the edemato-ascitic syndrome with an injectable aldosterone antagonist: 8109 CB].
    Dubarry JJ; Bancons J; Quinton A
    Bord Med; 1971 Dec; 4(12):3751-7. PubMed ID: 5146181
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical observation of effect of xiao gu san on cirrhosis ascites].
    Sun YX; Liu C
    Zhongguo Zhong Yao Za Zhi; 2004 Oct; 29(10):993-5. PubMed ID: 15631092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined ascitic--fluid and furosemide infusion: a therapeutic option for massive diuretic-resistant ascites and severe oliguria of hepatic cirrhosis.
    Onuigbo MA; Ozoh JO; Nusiem CA; Onyeagocha AC; Nwaneri O; Offodile AA; Ijoma CK
    Cent Afr J Med; 1991 Aug; 37(8):244-7. PubMed ID: 1807797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The combination of corticoids, spironolactone, salidiuretics and mannitol according to a particular schema of treatment of ascitic cirrhosis].
    Colucci CF
    Schweiz Med Wochenschr; 1966 May; 96(20):660-5. PubMed ID: 5988706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.